TL;DR:
- A woman who participated in the study, Jean Tyler, was found to have cancer which was removed, and she has since recovered.
- The AI flags up tissue that could be of concern to the medic carrying out the colonoscopy and is more efficient than human detection.
- About 2,000 patients from 10 NHS trusts participated in the trial.
- Jean Tyler received fantastic support and was well taken care of during her seven to eight visits last year.
- The study was led by gastroenterology consultant Professor Colin Rees from Newcastle University and his team of colleagues from South Tyneside and Sunderland NHS Trust, North Tees and Hartlepool NHS Foundation Trust, South Tees NHS Foundation Trust, Northumbria NHS Foundation Trust and Newcastle Upon Tyne Hospitals NHS Foundation Trust.
- Professor Rees described the study as “world-leading” in improving detection and believes AI will be a major tool in medicine in the coming years.
- The results of the study are expected to be published in the autumn and will be studied to see how it can help save lives from bowel cancer.
Main AI News:
A woman’s life was saved thanks to cutting-edge AI technology that detected bowel cancer in its early stages. Jean Tyler, a 75-year-old from South Shields, was part of a trial called Colo-Detect that was conducted at 10 NHS Trusts. The study was designed to determine the effectiveness of AI in detecting bowel cancer, a disease that claims the lives of approximately 16,800 people in the UK each year.
The AI system used in the trial would flag up tissue that may be of concern to the medic carrying out the colonoscopy, something that could be missed by the human eye. Mrs. Tyler was one of the 2,000 patients recruited for the trial and underwent a colonoscopy about a year ago. The AI system detected a number of polyps and an area of cancer on her colonoscopy, and she underwent surgery at South Tyneside District Hospital.
Thanks to the fantastic support she received, Mrs. Tyler has since recovered from her surgery. She praised the care she received and stated that she always says yes to research projects because she knows they can make things better for everyone. The trial was led by Professor Colin Rees, a gastroenterology consultant based at Newcastle University, and his team of colleagues working in South Tyneside and Sunderland NHS Trust.
The trial also involved North Tees and Hartlepool NHS Foundation Trust, South Tees NHS Foundation Trust, Northumbria NHS Foundation Trust, and Newcastle Upon Tyne Hospitals NHS Foundation Trust. Professor Rees described the trial as “world-leading” in improving the detection of bowel cancer and added that AI is likely to become a major tool in medicine in the coming years.
The results of the trial are expected to be published in the autumn and will be studied to determine how AI technology can help save lives from bowel cancer, the second biggest killer cancer in the UK. With the increasing use of AI and ML in healthcare, the future is looking bright for patients and medical professionals alike as they work together to find innovative ways to detect and treat life-threatening diseases.
Conlcusion:
The use of Artificial Intelligence (AI) in detecting bowel cancer has shown promising results in a trial conducted at 10 NHS Trusts. The study, called Colo-Detect, used AI to identify tissue that may be of concern during a colonoscopy, which could have been missed by the human eye. The AI was able to detect polyps and an area of cancer in a participant, leading to successful surgery and recovery.
The trial, led by Newcastle University and other NHS trusts, is expected to have a significant impact in improving detection and saving lives from bowel cancer, which claims approximately 16,800 lives a year in the UK. The results of the trial are expected to be published in the autumn. The use of AI in medicine is likely to become a major tool in the coming years, according to the study’s lead, Professor Colin Rees.
